| 1 |
33607534 | Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells. | 2021 Mar |
1 |
| 2 |
34031270 | Platelet-Derived Growth Factor Receptor-α Subunit Targeting Suppresses Metastasis in Advanced Thyroid Cancer In Vitro and In Vivo. | 2021 Sep 1 |
1 |
| 3 |
34781823 | Protein disulfide isomerase family 6 promotes the imatinib-resistance of renal cell carcinoma by regulation of Wnt3a-Frizzled1 axis. | 2021 Dec |
1 |
| 4 |
33022360 | Imatinib exhibit synergistic pleiotropy in the prevention of colorectal cancer by suppressing proinflammatory, cell survival and angiogenic signaling. | 2020 Dec |
1 |
| 5 |
29298654 | Determination of the Apoptotic Effect and Molecular Docking of Benzamide Derivative XT5 in K562 Cells. | 2018 |
1 |
| 6 |
28255316 | Imatinib and its combination with 2,5-dimethyl-celecoxibinduces apoptosis of human HT-29 colorectal cancer cells. | 2017 Feb |
2 |
| 7 |
28612529 | [The Mechanism of Combination using mTORC1/2 Inhibitor and Imatinib to Suppress Cell Proliferation of Ph +ALL Cell Line]. | 2017 Mar |
1 |
| 8 |
26708080 | Imatinib promotes apoptosis of giant cell tumor cells by targeting microRNA-30a-mediated runt-related transcription factor 2. | 2016 Feb |
1 |
| 9 |
24930392 | Modulation of imatinib cytotoxicity by selenite in HCT116 colorectal cancer cells. | 2015 Jan |
1 |
| 10 |
25786656 | Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer. | 2015 Jun 15 |
1 |
| 11 |
24088895 | Activin A induction of erythroid differentiation sensitizes K562 chronic myeloid leukemia cells to a subtoxic concentration of imatinib. | 2014 Jan 1 |
2 |
| 12 |
24527087 | In vitro effects of imatinib on CD34+ cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase. | 2014 Mar |
1 |
| 13 |
25322553 | [Gleevec induces apoptosis in K562 cells through activating caspase-3]. | 2014 Aug |
2 |
| 14 |
23434731 | Cleavage of BCR-ABL transcripts at the T315I point mutation by DNAzyme promotes apoptotic cell death in imatinib-resistant BCR-ABL leukemic cells. | 2013 Aug |
1 |
| 15 |
23613979 | Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation. | 2013 |
2 |
| 16 |
22388075 | Imatinib induces H2AX phosphorylation and apoptosis in chronic myelogenous leukemia cells in vitro via caspase-3/Mst1 pathway. | 2012 Apr |
5 |
| 17 |
21658383 | Apoptotic effect of imatinib on human colon adenocarcinoma cells: influence on actin cytoskeleton organization and cell migration. | 2011 Sep 30 |
1 |
| 18 |
20031210 | Molecular characterization and prognostic significance of FLT3 in CML progression. | 2010 Aug |
1 |
| 19 |
20094798 | Enhancement of imatinib-induced apoptosis of BCR/ABL-expressing cells by nutlin-3 through synergistic activation of the mitochondrial apoptotic pathway. | 2010 May |
2 |
| 20 |
20132660 | Nilotinib significantly induces apoptosis in imatinib-resistant K562 cells with wild-type BCR-ABL, as effectively as in parental sensitive counterparts. | 2010 Feb |
1 |
| 21 |
20307198 | Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells. | 2010 Jul |
1 |
| 22 |
20723293 | [Effects of STI571 combined with As₂O₃ on proliferation, apoptosis and caspase 3, Bcl-xL expression of K562 cells]. | 2010 Aug |
4 |
| 23 |
19058199 | Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo. | 2009 Mar 1 |
1 |
| 24 |
19340007 | Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells. | 2009 Aug |
1 |
| 25 |
19490758 | Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells. | 2009 Jun |
1 |
| 26 |
18401414 | Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells. | 2008 May |
1 |
| 27 |
18843975 | [Imatinib induces c-kit positive myeloma cells apoptosis]. | 2008 Apr |
1 |
| 28 |
17926190 | (-)Gossypol and its combination with imatinib induce apoptosis in human chronic myeloid leukemic cells. | 2007 Nov |
1 |
| 29 |
16596277 | STI571 (Glivec) induces cell death in the gastrointestinal stromal tumor cell line, GIST-T1, via endoplasmic reticulum stress response. | 2006 May |
1 |
| 30 |
15657060 | c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic response to DNA damage. | 2005 Mar 25 |
1 |
| 31 |
15770664 | Fast apoptosis and erythroid differentiation induced by imatinib mesylate in JURL-MK1 cells. | 2005 May 15 |
1 |
| 32 |
12850478 | Involvement of Akt kinase in the action of STI571 on chronic myelogenous leukemia cells. | 2003 Jul-Aug |
2 |
| 33 |
11782377 | Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells. | 2002 Jan 1 |
1 |
| 34 |
12021410 | Inhibition of c-Abl with STI571 attenuates stress-activated protein kinase activation and apoptosis in the cellular response to 1-beta-D-arabinofuranosylcytosine. | 2002 Jun |
1 |
| 35 |
12231544 | Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells. | 2002 Sep |
1 |
| 36 |
12411057 | The mechanism of STI571 inducing apoptosis of K562 cells. | 2002 Jun |
1 |
| 37 |
11179439 | The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces differentiation and apoptosis in human leukemia K562 cells. | 2001 Mar |
1 |